Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020 - Report Focus
The report “Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:-
Emerging Market Trends
Advancements in the Technological Space
Market Demand Of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Investment Strategies
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
The analysis primarily deals with human biobanking ownership market. Further, the subdivided categories include:
1. Private Banks
a. Disease-Based Banks
b. Population-Based Banks
c. Academics
2. Public Banks
a. Disease-Based Banks
b. Population-Based Bank2
c. Academics
The period considered for the human biobanking ownership market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 1250 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 138 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
- I. REPORT FOCUS
- A. INTRODUCTION
- BIOREPOSITORY
- CLASSIFYING BIOBANKS
- STORING SAMPLES IN A BIOBANK
- BIOSPECIMEN SECURITY AND STORAGE
- THE GENERATIONAL EVOLUTION OF BIOBANK
- PUTTING TOGETHER A BIO BANK WITH ITS REQUIREMENTS AND CAPACITIES
- TECHNICAL REQUIREMENTS
- FUNCTIONAL REQUIREMENTS
- BIOREPOSITORY OPERATIONS
- GETTING A BIOREPOSITORY ACCREDITED
- THE ROLE OF SYNTHETIC DATA IN BIOBANK ANALYSIS
- B. BIOBANKING BENEFITS
- CONCLUSION
- C. BIOSPECIMENS (COLLECTION, PROCESSING, STORAGE, RETRIEVAL AND DISSEMINATE)
- BIOSPECIMENS IN CANCER RESEARCH
- BIOSPECIMENS - THE LEGACY PLAN
- DECADES OLD SPECIMENS MAY BE TODAY’S RESEARCH TREASURES
- BIOSPECIMEN MANAGEMENT SYSTEM
- THE MODERN APPROACH TO BIOBANKING
- ISOLATING STOMACH-CELL POPULATIONS USING LCM
- RESULTS FROM THE BPV PROGRAM
- EVALUATION OF PRE-ANALYTICAL FACTORS ON IDENTIFICATION OF COPY NUMBER VARIATIONS
- THE IMPACT OF EX-VIVO ISCHEMIA TIME ON QUALITY OF RNA
- THE IDEAL PHYSICAL ENVIRONMENT FOR BIOSPECIMENS
- CASE STUDY: ADVANCED IT SYSTEM FOR RESEARCH BIOREPOSITORY
- PHYSICAL PHENOMENON AT LOW TEMPERATURES
- BIOLOGICAL PHENOMENON AT LOW TEMPERATURES
- STORAGE METHODS FOR VARIOUS BIOSPECIMENS
- 1. STORING PROTEINS AND PURIFIED NUCLEIC ACIDS
- 2. STORING CRYO-PRESERVED CELLS
- 3. STORING TISSUES
- CONCLUSION
- 1. COMPILATION OF STUDIES DESCRIBING THE STABILITY OF SPECIFIC BIOMARKERS FOR BIOSPECIMENS (BIOFLUIDS, CELLS, TISSUES) AS A FUNCTION OF STORAGE TEMPERATURE/DURATION
- TRANSPORTING BIOSPECIMENS
- EFFECTS OF TRANSPORTATION ON MONONUCLEAR CELLS
- FINDING BIO-SAMPLES
- OUT OF THE COLD-DRY STATE
- BANKING ON SUCCESS FOR PRECISION MEDICINE
- THE CLOSE OF THE ULTIMATE PERIOD IN BIO-BANKING
- COST OF VALUE STUDY: RELATE THE THEORY TO BIOBANKS
- MALFUNCTION COSTS:
- EXTERNAL STOPPAGE COSTS:
- BIOBANK ECONOMIC MODELING TOOL: A COST IMPROVEMENT DEVICE FOR CONTINUITY OF BIO-BANKS
- INSTITUTION OF AN ISO15189 ACCREDITED BIO-BANK FOR GLOBAL CLINICAL RESEARCH STUDIES
- CRITICAL MOVES TO BUILD BIO-BANKS: STAGE WISE PROCESS FOR LOW INCOME NATIONS
- THE INSTITUTION OF A BIO-BANK AND COHORT NETWORK (BCNET) FOR LOW AND MIDDLE INCOME COUNTRIES
- BIO-BANKING AND TRANSLATIONAL MEDICINE: THE SCHOLARLY OUTLOOK
- A WORKABLE METHODOLOGY DEVISED BY BIO-BANK GRAZ: A REPRESENTATION FOR OTHER UNIVERSITY-BASED INSTITUTIONS
- THE SUSTAINABILITY ISSUE OF A COMMUNITY HOSPITAL-BASED BIO-BANK AND CORE MOLECULAR LABORATORY: THE BEAUMONT UNDERSTANDING
- TO MAINTAIN A DISEASE CENTERED BIO-BANKING - AN ACTIVE APPROACH
- D. BIOBANKING PRINCIPLES
- NORMS BASED ON INTERFACE COMPREHENSION
- DATA STANDARDS ARE NOT MAXIMIZED IN RESEARCH BIO-BANKING
- DATA STANDARDS - PROPOSED BY OBBR AND ISBER
- DATA STANDARDS PROGRAM FOR BIO-BANKS
- DESIGN OF A REGISTRY OF STANDARD OPERATING PROTOCOLS FOR TISSUE COMPILATION
- E. PATH BREAKING TECHNOLOGIES
- THE BIO-BANK INFORMATION MANAGEMENT SYSTEM LIFE CYCLE ORGANIZATION AND THE BIMS CLOUD MANAGEMENT PLATFORM
- AMALGAMATION OF STANDARD PRE-ANALYTICAL CODE WITH BIO-BANK ORGANIZATION SOFTWARE FREEZER PRO
- EVALUATION OF COMPUTERIZATION TECHNOLOGIES AND PHYSICAL STORAGE AND RECOVERY
- FUTURE OUTLOOK AND CONCERNS IN THE SETUP OF SOFTWARE SOLUTIONS IN AN INTERDISCIPLINARY CLINICAL BIOBANK
- A MECHANICAL LABORATORY WORKFLOW FOR STOOL DNA REMOVAL
- CONSISTENT WORKFLOW FOR BIO-MATERIAL APPEALS
- PARTIALLY COMPUTERIZED BIO-BANK SAMPLE PROCESSING WITH A 384 HIGH DENSITY SAMPLE TUBE ROBOT DEPLOYED IN CANCER AND CARDIOVASCULAR RESEARCH
- AN AUTONOMOUS APPRAISAL OF THE CRYOXTRACT CXT350 FROZEN BIO-SPECIMEN CORING APPLICATION WITH TISSUE AND STOOL FECAL SAMPLES
- HEAT STANDARDIZATION OF TISSUE SAMPLES SUPPORTS MEASUREMENT WITHOUT INTRUSION FROM POST-MORTEM OCCURRENCES AND PERMITS FOR REFINEMENT BECAUSE OF MINIMIZED INTRA GROUP VARIABILITY
- BIOT CRYOCARRIER - STANDARDIZED CRYOGENIC TEMPERATURE HANDLING OF BIOSPECIMENS
- PROTECTION BY VAPORIZATION FOR BIO-BANKING
- OPTIMUM SPECIMEN SECURITY WITH COMPLETE AUTOMATION CHARACTERISTICS: THE AUTOMATED LN2 VAPOUR PHASE FREEZER
- EXERCISE OF ELECTRONIC P-CHIPS IN A MONO AND DUOTAGGING SYSTEM FOR SAMPLE TUBES USED IN BIO-BANKING
- SAMPLE TRAIL AND PREREQUISITE WITH IPLEX® PRO SAMPLE ID
- USAGE OF AN E-CONSENT SYSTEM FOR BIO-BANK PATIENT CONSENT – THE THREE WHYS
- CELL LINE VERIFICATION WITH THE USE OF SNP TRACE™ PANEL: A HIGH-THROUGHPUT, AFFORDABLE SNPBASED INTERFACE FOR FINGERPRINTING, IDENTIFYING INFECTIVITY, AND ESTABLISH ORIGIN OF DERIVATIVE CELL LINES
- NEXT-GENERATION DNA SEQUENCING WITH SUSTAINED PRESERVED SERUM SAMPLES
- AN ASSESSMENT OF FROZEN ALIQUOTTING APPLICATION FOR THE STABILIZATION OF SMALL MOLECULE AND PEPTIDES IN BIO-ANALYTICAL TECHNOLOGY
- F. BIOBANKING PERFORMANCES
- PERFORMANCES INSIDE THE BIO-BANK
- ETHICAL, LEGAL AND APPROPRIATE STRATEGIES
- SOCIETAL COMMITMENT FOR GROWTH OF CDC POLICY LEADING SUPERVISION OF SPECIMENS ATTAINED FROM AMERICAN INDIAN/ALASKA NATIVE PEOPLE
- LEGAL AND REGULATORY HURDLES THAT IMPACT COMPLETION OF AN INTER-INSTITUTIONAL BIO-BANK SYSTEM
- IN –DEPTH APPRAISAL ON BIO-BANKING PERFORMANCES
- SPECIMEN RESEARCH
- SAFEGUARD AND CONTROL SAMPLE DATA
- BIO-SAMPLES PRESERVATION AND SAFETY PRECAUTIONS
- MONITOR SAMPLES THROUGH TRANSPORT
- FARM OUT SAMPLES
- CONCLUSION
- G. BIOBANK OWNERSHIP
- PRIVATE BANKS
- PUBLIC-PRIVATE PARTNERSHIP IN BIO-BANKING
- PUBLIC BANKS
- COST RECOVERY FOR A PUBLIC BIOBANK – INTRODUCTION
- BIOBANKS: ASSOCIATED COSTS
- 2. TASKS IN BIOBANKING IN BRIEF
- 3. MODELS FOR COLLABORATION AROUND BIOBANKING COSTS
- MODERN DEVELOPMENTS IN BIOBANK PRINCIPLES
- H. HUMAN BIOBANKING OWNERSHIP - GEOGRAPHY MARKET BRIEFING
- NORTH AMERICA
- 4. HUMAN BIOBANKING OWNERSHIP MARKET - PRIVATE BANKS AND PUBLIC BANKS FOR NORTH AMERICA CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 5. HUMAN BIOBANKING OWNERSHIP MARKET - PRIVATE BANKS AND PUBLIC BANKS - % OF NORTH AMERICAN MARKET VALUE - (2017-2020)
- EUROPE
- 6. HUMAN BIOBANKING OWNERSHIP MARKET - PRIVATE BANKS AND PUBLIC BANKS FOR EUROPE CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 7. HUMAN BIOBANKING OWNERSHIP MARKET - PRIVATE BANKS AND PUBLIC BANKS - % OF EUROPEAN MARKET VALUE - (2017-2020)
- ASIA-PACIFIC
- 8. HUMAN BIOBANKING OWNERSHIP MARKET - PRIVATE BANKS AND PUBLIC BANKS FOR ASIA-PACIFIC CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 9. HUMAN BIOBANKING OWNERSHIP MARKET - PRIVATE BANKS AND PUBLIC BANKS - % OF ASIA-PACIFIC MARKET VALUE - (2017-2020)
- REST OF WORLD
- 10. HUMAN BIOBANKING OWNERSHIP MARKET - PRIVATE BANKS AND PUBLIC BANKS FOR REST OF WORLD CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 11. HUMAN BIOBANKING OWNERSHIP MARKET - PRIVATE BANKS AND PUBLIC BANKS - % OF REST OF WORLD MARKET VALUE - (2017-2020)
- I. PRIVATE BIOBANKS - GEOGRAPHY MARKET BRIEFING
- NORTH AMERICA
- 12. PRIVATE BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS, ACADEMICS FOR NORTH AMERICA CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 13. PRIVATE BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS, ACADEMICS - % OF NORTH AMERICAN MARKET VALUE - (2017-2020)
- EUROPE
- 14. PRIVATE BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS, ACADEMICS FOR EUROPE CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 15. PRIVATE BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS, ACADEMICS - % OF EUROPEAN MARKET VALUE - (2017-2020)
- ASIA-PACIFIC
- 16. PRIVATE BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS, ACADEMICS FOR ASIA-PACIFIC CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 17. PRIVATE BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS, ACADEMICS - % OF ASIA-PACIFIC MARKET VALUE - (2017-2020)
- REST OF WORLD
- 18. PRIVATE BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS, ACADEMICS FOR REST OF WORLD CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 19. PRIVATE BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS, ACADEMICS - % OF REST OF WORLD MARKET VALUE - (2017-2020)
- J. PUBLIC BIOBANKS - GEOGRAPHY MARKET BRIEFING
- NORTH AMERICA
- 20. PUBLIC BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS AND ACADEMICS FOR NORTH AMERICA CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 21. PUBLIC BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS AND ACADEMICS - % OF NORTH AMERICAN MARKET VALUE - (2017-2020)
- EUROPE
- 22. PUBLIC BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS AND ACADEMICS FOR EUROPE CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 23. PUBLIC BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS AND ACADEMICS - % OF EUROPEAN MARKET VALUE - (2017-2020)
- ASIA-PACIFIC
- 24. PUBLIC BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS AND ACADEMICS FOR ASIA-PACIFIC CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 25. PUBLIC BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS AND ACADEMICS - % OF ASIA-PACIFIC MARKET VALUE - (2017-2020)
- REST OF WORLD
- 26. PUBLIC BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS AND ACADEMICS FOR REST OF WORLD CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 27. PUBLIC BIOBANKS MARKET - DISEASE-BASED BANKS, POPULATION-BASED BANKS AND ACADEMICS - % OF REST OF WORLD MARKET VALUE - (2017-2020)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook